Interferon-λ in HCV Infection and Therapy di Michael D. Robek, Nicole E. Pagliaccetti

Testo

Epigenetic reprogramming of the type III interferon response potentiates antiviral activity and suppresses tumor growth. di Siyuan Ding, William Khoury-Hanold, Akiko Iwasaki, Michael D Robek

Testo

Virus-based vaccine vectors with distinct replication mechanisms differentially infect and activate dendritic cells di Carolina Chiale, Anthony M. Marchese, Yoichi Furuya, Michael D. Robek

Testo

Functional characterization of the putative hepatitis B virus core protein late domain using retrovirus chimeras. di Mayra L Garcia, Tracy D Reynolds, Walther Mothes, Michael D Robek

Testo

CD4+ T cells reverse surface antigen persistence in a mouse model of HBV replication di Jacob T. Bailey, Safiehkhatoon Moshkani, Catherine Rexhouse, Jesse L. Cimino, Michael D. Robek

Testo

Modified Alphavirus-Vesiculovirus Hybrid Vaccine Vectors for Homologous Prime-Boost Immunotherapy of Chronic Hepatitis B di Carolina Chiale, Timur O. Yarovinsky, Stephen W. Mason, Bhaskara R. Madina, Manisha Menon, Marie M. Krady, Safiehkhatoon Moshkani, Anasuya Chattopadhyay Pal, Bijan Almassian, John K. Rose, Michael D. Robek, Valerian Nakaar

Testo

Virus-like Vesicles Expressing Multiple Antigens for Immunotherapy of Chronic Hepatitis B di Timur O. Yarovinsky, Stephen W. Mason, Manisha Menon, Marie M. Krady, Maria Haslip, Bhaskara R. Madina, Xianyong Ma, Safiehkhatoon Moshkani, Carolina Chiale, Anasuya Chattopadhyay Pal, Bijan Almassian, John K. Rose, Michael D. Robek, Valerian Nakaar

Testo